A randomized controlled study of PPOS protocol in IVF / ICSI treatment of polycystic ovary syndrome

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045153

Enrollment

Unknown

Registered

2021-04-07

Start date

2021-04-12

Completion date

Unknown

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome

Interventions

gonadotropin-releasing hormone antagonist group:Start using Gn drugs 150-225IU/d on the 2-3 days of menstruation, and start adding GnRH antagonists from the 6th day of Gn or when at least one follicle

progestin-primed ovarian stimulation group:Begin oral progesterone capsules 200mg/d on the 2-3 days of menstruation, and give Gn drugs at the same time

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.The age of the patients was < 40 years old; 2.With indications for IVF treatment; 3.According to the criteria of diagnosis of Rotterdam polycystic ovarian syndrome in 2003.

Exclusion criteria

Exclusion criteria: 1.Uterine malformation; 2.Endometrial lesions; 3.Combined with other medical and surgical diseases; 4.Combined with endometriosisadenomyomauterine myomaand hydrosalpinx, etc.; 5.Combined with other endocrine diseases.

Design outcomes

Primary

Measure	Time frame
high quality embryo rate;	—

Countries

China

Contacts

Public ContactLiang Yu

Beijing Obstetrics and Gynecology Hospital, Capital Medical University

liangyu1981830@163.com+86 13141267501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026